(RPRX) Royalty Pharma - Performance 41% in 12m
RPRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-17.82%
#78 in Peer-Group
Rel. Strength
81.91%
#1344 in Stock-Universe
Total Return 12m
41.02%
#24 in Peer-Group
Total Return 5y
-17.73%
#79 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 14.3 |
| P/E Forward | 11.7 |
| High / Low | USD |
|---|---|
| 52 Week High | 36.14 USD |
| 52 Week Low | 23.96 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 83.37 |
| Buy/Sell Signal +-5 | 1.43 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RPRX (41%) vs XLV (-6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-5.69% | 124% | 337% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
7.32% | -14.6% | 405% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NVS NYSE Novartis |
6.6% | 16.7% | 77.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
2.29% | 3% | 48.6% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-3.55% | 4.95% | 48.8% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.76% | -5.21% | 112% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.44% | -8.57% | 48.1% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.55% | -9.51% | 43.2% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: RPRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RPRX
| Total Return (including Dividends) | RPRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.90% | 1.67% | 4.52% |
| 3 Months | 16.00% | -7.84% | 10.25% |
| 12 Months | 41.02% | -6.02% | 14.16% |
| 5 Years | -17.73% | 47.32% | 116.91% |
| Trend Score (consistency of price movement) | RPRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 93.3% | 41.7% | 79.1% |
| 3 Months | 92.8% | -51% | 91.7% |
| 12 Months | 74.2% | -70.9% | 44% |
| 5 Years | -75.5% | 88% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th81.87 | 8.09% | 5.14% |
| 3 Month | %th69.95 | 25.86% | 5.21% |
| 12 Month | %th88.60 | 50.05% | 23.53% |
| 5 Years | %th56.99 | -44.15% | -62.07% |
FAQs
Does Royalty Pharma (RPRX) outperform the market?
Yes,
over the last 12 months RPRX made 41.02%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.02%.
Over the last 3 months RPRX made 16.00%, while XLV made -7.84%.
Performance Comparison RPRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RPRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.1% | 5.4% | 38.4% | 27% |
| US NASDAQ 100 | QQQ | -1.8% | 4.4% | 37% | 27% |
| German DAX 40 | DAX | -2% | 9.5% | 23.2% | 10% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.5% | 7.4% | 42.4% | 24% |
| Hongkong Hang Seng | HSI | -1.5% | 3.1% | 21.2% | 5% |
| India NIFTY 50 | INDA | -1.5% | 7.6% | 37.5% | 41% |
| Brasil Bovespa | EWZ | -0.4% | 6.4% | 16.8% | 31% |
RPRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.3% | 3% | 32.1% | 13% |
| Consumer Discretionary | XLY | -0.6% | 8% | 46.4% | 21% |
| Consumer Staples | XLP | 2.4% | 11.1% | 39.5% | 32% |
| Energy | XLE | 2.2% | 5.4% | 41.1% | 44% |
| Financial | XLF | -0.9% | 7.4% | 35.2% | 13% |
| Health Care | XLV | -0% | 8.2% | 45.1% | 47% |
| Industrial | XLI | -0.7% | 6.7% | 31.6% | 18% |
| Materials | XLB | 0.2% | 7.6% | 37.6% | 38% |
| Real Estate | XLRE | 3.6% | 10.4% | 40.1% | 29% |
| Technology | XLK | -1.9% | 1.5% | 36.2% | 30% |
| Utilities | XLU | 1.2% | 8.9% | 34.7% | 17% |
| Aerospace & Defense | XAR | -3% | 0.3% | 17.3% | -11% |
| Biotech | XBI | 0.4% | 6.7% | 51.2% | 52% |
| Homebuilder | XHB | 0.2% | 6% | 48.9% | 40% |
| Retail | XRT | 1.1% | 7.8% | 45.8% | 34% |
RPRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 5.4% | 0.84% | 45.6% | 51% |
| Natural Gas | UNG | 3.1% | 6.5% | 51.8% | 41% |
| Gold | GLD | 4.5% | 11.3% | 18.4% | 1% |
| Silver | SLV | 2.4% | 2.2% | 20.1% | 20% |
| Copper | CPER | -2% | 1.3% | 20% | 26% |
RPRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.6% | 8.1% | 42.3% | 40% |
| iShares High Yield Corp. Bond | HYG | 0.8% | 8.4% | 39% | 31% |